Heath Lukatch

Manufactures biopharmaceutical products

Operates as a clinical stage biotechnology company

Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases

Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions

Manufactures pharmaceutical products

Operates as a sacroiliac joint medical device company

Develops neuroscience based technology

Operates as a management consulting firm

Functions as a College/University

Discovers and develops medicines

Functions as a College/University

SightLine Partners invests in both public and private companies located in the United States. The firm focuses on medical technology, digital health, life science and healthcare service sectors. It provides financing for buyout and growth transactions. The firm makes follow-on investments.

TPG Growth invests in middle-market companies located in the United States, Asia and other selected united regions. The firm focuses on a broad range of sectors and industries. It provides financing for growth and buyouts capital requirements.

Manufactures and designs medical products for treatment of early-stage breast cancer in women

Manufactures aerosol drug products

Novo Ventures invests in companies located in Europe, the United States and Asia. The firm targets companies operating in the fields of health technology, health services, biotechnology and medical specialties sectors. It provides financing for early stage capital requirements.

Develops biopharmaceutical and therapeutic drugs for central nervous system disorders

Discovers and develops new drug candidates for the treatment & management of pain

Provides therapeutic treatments for infertility and miscarriages

Develops products for unmet medical needs in psychiatry and neurology

Designs, manufactures and distributes biomedical equipment

Provides licensing and royalty services for medicines

Provides drug development programs for inflammatory diseases

Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world.

Develops non-surgical treatments for eye diseases

Develops vaccines for infectious diseases

Lagunita Biosciences invests in companies located in the United States. It focuses on companies operating in the fields of ophthalmology, protein engineering, drug discovery, surgical devices and mobile health services. It participates in early stage transactions.

Operates as a biopharmaceutical company for migraine and debilitating conditions

TPG Biotech seeks investment opportunities in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, medical technology, and healthcare services. It provides financing for early and later stage capital requirements.

Develops rescue therapy for uncontrolled epileptic seizures

Develops electroencephalography medical device and related AI based platform

Operates as a biotechnology company

Red Tree Venture Capital seeks investment opportunities in companies located in the US. The firm targets companies operating in the fields of life science innovation sectors. It provides financing for early stage capital requirements.

Develops and commercializes medicines for treating neuron diseases

Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors

Develops closed-loop neuro-modulation technology for mental health conditions

Engages in generation of adoptive cell therapies for cancer treatment

Provides therapeutic services for treatment of severe allergic diseases